secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001299130-24-000185
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pacific Biosciences CCO Jeff Eidel to depart Nov 15 amid commercial restructuring
--------------------------------------------------------------------------------

- Jeff Eidel notified of separation as Chief Commercial Officer on November 11, 2024.
- Separation effective November 15, 2024, due to internal restructuring of commercial organization.
- Eidel's responsibilities reallocated to CEO Christian Henry; no compensation increase for Henry.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000185/0001299130-24-000185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000185/pacb-20241111.htm
  HTML page:      https://secwatch.observer/filing/0001299130-24-000185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer